A 25% weekly spike in the CBOE Volatility Index to 24.13 defined the mood across financial markets heading into the latter half of November, even as the gauge eased modestly on Wednesday itself.

Silver was the week’s worst-performing major commodity, shedding 8.19% to settle at $45.01 per ounce, while gold dropped 3.70% on the week to $3,742.50 per ounce despite a partial intraday recovery attempt.

WTI crude oil was not far behind, sliding 7.81% on the week to $81.64 per barrel, and copper lost 6.64% to reach $5.6760 per pound as industrial demand sentiment deteriorated sharply.

Natural gas stood out as the lone commodity gainer, advancing 4.21% on Wednesday and 3.50% for the week to $3.343 per MMBtu, offering a narrow counterpoint to the broader selloff.

The Dow Jones Industrial Average bore the heaviest index damage, tumbling 4.03% on the week to 50,236.18, while the PHLX Semiconductor Index suffered an even steeper weekly decline of 5.66% to 9,572.53.

The Nasdaq Composite and Russell 2000 managed to eke out modest Wednesday gains, up 0.22% and 1.06% respectively, though both indexes remained firmly negative on a weekly basis.

The 10-year U.S. Treasury yield slipped to 5.06%, falling 9 basis points over the week, providing a marginal offset to the pressure bearing down on risk assets.

Against that turbulent backdrop, Cisco (NASDAQ: CSCO) delivered a standout fiscal first quarter, reporting revenue of $18.5 billion, a 24% year-over-year increase, alongside record GAAP earnings per share of $1.14, up 58% from the prior-year period.

The networking giant also raised its full-year revenue guidance to a range of $74.8 billion to $75.8 billion and lifted its AI infrastructure revenue forecast for hyperscalers to $9 billion in fiscal 2027, more than double the figure recorded in fiscal 2026.

Eli Lilly (NYSE: LLY) broke ground on a $3.5 billion injectable medicine manufacturing facility in Pennsylvania’s Lehigh Valley, part of a broader $50 billion commitment to U.S. production expansion that now encompasses 10 new domestic sites announced since 2020.

The Lehigh Valley plant, which will produce experimental obesity treatment retatrutide among other medicines, is expected to generate 850 permanent high-wage positions and roughly 2,000 construction jobs, with operations targeted for 2031.

Alimentation Couche-Tard (TSX: ATD) cleared the final regulatory hurdle for its tender offer for Poland’s Zabka Group after the Polish Office of Competition and Consumer Protection issued approval on November 13, 2026, following earlier sign-offs from Romanian and European Union authorities.

The offer is set to close December 7, 2026, with Zabka shareholders receiving PLN 32.00 per share in cash through Couche-Tard’s Circle K Polska subsidiary, and the company has signaled it may pursue compulsory acquisition and a Warsaw Stock Exchange delisting if it secures at least 95% of voting rights.

Collins Aerospace (NYSE: RTX) broke ground on what it described as India’s first propeller maintenance, repair, and overhaul facility authorized by a foreign aerospace original equipment manufacturer, located in Bengaluru and targeting service for ATR 42/72 and Airbus C295 platforms across Asia Pacific.

The facility, which will employ up to 50 technicians and engineers and is expected to be operational by early 2029, extends a commitment that has seen Collins deploy more than $200 million in India over the past five years.

SAP SE (NYSE: SAP) disclosed that Executive Board member and Chief Customer Officer Thomas Saueressig will depart to pursue an external opportunity, remaining in his role through the end of March 2027 while Emmanuel Raptopoulos assumes his responsibilities on an interim basis starting in January.

The company’s Supervisory Board has begun the formal process of identifying Saueressig’s permanent successor, and SAP said only that “we thank him for his commitment and wish him all the best for the future.”